The growth of this market can be attributed to the rising preference for continuous manufacturing in the biopharmaceutical industry and the increasing demand for biopharmaceuticals across the globe. The report Hollow Fiber Filtration Market is projected to reach USD 517.4 million by 2023 from USD 274.7 …
Expected Revenue Growth:The chiral chromatography column marketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 millionin 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of …
The live cell imaging market size is projected to reach USD 2.8 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period.
The Cell Surface Markers Market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, growing at a CAGR of 8.1%
The ELISpot and FluoroSpot market is expected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2%.
The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market. The Blood Screening Market is projected to reach USD 3.5 …
What This Report Will Provide? This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate …
What This Report Will Provide? This study involved four major activities in estimating the current size of the interventional oncology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to …
The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period. The major factors driving the CRISPR technology market include the rising funding from government and private …
The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 4.4%.
The Real World Evidence Solutions market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3%
Global Leaders: Some of the prominent players in the NGS sample preparation market include Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), Beckman Coulter (a subsidiary of Danaher), Becton, Dickinson and Company (BD) (US), Pacific Biosciences of California (US), …
The key factors driving the growth of this market are the growing prevalence of chronic diseases (such as cancer, diabetes, and cardiovascular diseases), favorable reimbursement scenario in major markets, and technological advancements in injector devices. The Wearable Injectors Market is projected to reach USD 9.41 …
Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements and new product launches, and rising R&D expenditure for developing new dialysis products. The report Hemodialysis …